Nurse Practitioner · Richmond, VA
NPI
1912081571
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1250 E Marshall St, Internal Medicine/Hematology/Oncology
Richmond, VA, 23298
Phone (804) 628-1934
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
775 services
Medicare patients, 2024
238
Average age 73
Drug cost, 2024
$16.2M
1,782 prescriptions
Company payments, 2025
$26K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin Brigle was code 99215 (office e&m - established), 447 times for 129 patients. In total Kevin Brigle billed 775 services in 8 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 447 | 129 | $92.10 | $41K |
| 99214 Office E&M - Established | Facility | 220 | 109 | $59.70 | $13K |
| 99213 Office E&M - Established | Facility | 76 | 53 | $35.00 | $2,660 |
| 99204 Office E&M - New | Facility | 13 | 13 | $86.04 | $1,119 |
By year: 2022 $59K for 865 services; 2023 $59K for 820 services; 2024 $59K for 775 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin Brigle prescribed most often to Medicare patients was Lenalidomide, with 261 prescriptions and refills. In total Kevin Brigle wrote 1,782 Medicare prescriptions that cost $16.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 261 | 261 | 37 | $3.5M |
| Revlimid Lenalidomide | 221 | 221 | 40 | $4.1M |
| Acyclovir Generic | 205 | 413 | 53 | $4,473 |
| Pomalyst Pomalidomide | 197 | 197 | 27 | $4.3M |
| Imatinib Mesylate Generic | 54 | 72 | Under 11 | $215K |
| Venclexta Venetoclax | 51 | 51 | 11 | $396K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 54 | Under 11 | $127 |
| Gabapentin Generic | 40 | 51 | 11 | $433 |
| Ondansetron Hcl Generic | 39 | 39 | 17 | $368 |
| Dexamethasone Generic | 38 | 56 | 18 | $683 |
| Prochlorperazine Maleate Generic | 36 | 36 | Under 11 | $408 |
| Eliquis Apixaban | 30 | 58 | 11 | $32K |
| Bosulif Bosutinib | 26 | 26 | Under 11 | $353K |
| Hydroxyurea Generic | 23 | 23 | Under 11 | $361 |
| Prednisone Generic | 21 | 27 | Under 11 | $34.46 |
Brand drugs: 710 claims; generic drugs: 1,072 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin Brigle $26K ($26K in general payments such as food, travel and fees) from 8 companies. The largest payer was Pfizer Inc. with $6,665.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.